Who
Travis Alan Coy
Director
Company insider
Files Form 4 as: Director, TRex Bio; Chief Financial Officer, Immunocore Holdings.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 1 Jan 2025
- Last trade
- 8 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Oct 2026filed 8 Oct 2026 | TRXB TRex Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —17,500 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,353 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —95,637 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,353 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —95,637 at $0.00 | filing |
| 1 Jan 2025filed 3 Jan 2025 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —274,033 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.